Your session is about to expire
← Back to Search
Alinity m HR HPV for Human Papillomavirus
Study Summary
This trial will be testing two different ways of collecting cervical cancer screening specimens in order to determine which is more effective in detecting disease.
- Human Papillomavirus
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Who is running the clinical trial?
Media Library
- You are 25 years of age or older.You are attending a participating clinic for routine cervical cancer screening following screening guidelines.You have not had your cervix removed.You are willing and able to allow collection of two cervical cytology specimens.Women can participate if they meet these requirements:
- Group 1: Alinity m HR HPV
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How extensive is the geographical coverage of this research endeavor?
"This investigation is enrolling patients from Physicians' Research Options in Lakewood, Colorado; Rex Garn Mabey in Las Vegas, Nevada; and Medical Research Center of Memphis, LLC in Memphis, Tennessee. Additionally there are 58 additional medical centres involved."
Are there any ongoing opportunities for individuals to participate in this research?
"The posted information on clinicaltrials.gov points to this trial being inactive, having been initially advertised in February 2021 and last updated November 2022. While no longer recruiting participants, there are 367 other studies actively seeking enrollees at present."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
What site did they apply to?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- Health Awareness, Inc.: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger